Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yuichi,Yamasaki

第一单位： Department of Pediatrics, Kagoshima University Hospital, Kagoshima.

作者： Yuichi,Yamasaki ^[1] ; Norimoto,Kobayashi ^[2] ; Shinji,Akioka ^[3] ; Kazuko,Yamazaki ^[4] ; Shunichiro,Takezaki ^[5] ; Haruna,Nakaseko ^[6] ; Asami,Ohara ^[6] ; Kenichi,Nishimura ^[7] ; Yutaka,Nishida ^[8] ; Satoshi,Sato ^[9] ; Takayuki,Kishi ^[10] ; Motomu,Hashimoto ^[11] ; Masaaki,Mori ^[12] ; Yuka,Okazaki ^[13] ; Masataka,Kuwana ^[13] ; Akiko,Ohta ^[14]

作者单位： Department of Pediatrics, Kagoshima University Hospital, Kagoshima. ^[1] Department of Pediatrics, Shinshu University School of Medicine, Matsumoto. ^[2] Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto. ^[3] Division of Rheumatology and Allergology, Department of Internal Medicine, St Marianna University School of Medicine, Kawasaki. ^[4] Department of Pediatrics, Hokkaido University Hospital, Sapporo. ^[5] Department of Infection and Immunology, Aichi Children's Health and Medical Center, Obu. ^[6] Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama. ^[7] Department of Pediatrics, Graduate School of Medicine, Gunma University, Maebashi. ^[8] Department of Infectious Diseases and Immunology, Saitama Children's Medical Center, Saitama. ^[9] Department of Pediatrics, Tokyo Women's Medical University, Tokyo. ^[10] Department of Advanced Medicine for Rheumatic Diseases, Kyoto University, Kyoto. ^[11] Department of Lifetime Clinical Immunology, Tokyo Medical and Dental University. ^[12] Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo. ^[13] Division of Public Health, Department of Social Medicine, Saitama Medical University Faculty of Medicine, Moroyama, Saitama, Japan. ^[14]

关键词 anti-MDA5 antibody anti-NXP2 antibody anti-TIF1γ antibody juvenile idiopathic inflammatory myopathies myositis-specific antibody prognosis